首页> 外文期刊>Journal of psychopharmacology >Dose reduction of risperidone and olanzapine can improve cognitive function and negative symptoms in stable schizophrenic patients: A single-blinded, 52-week, randomized controlled study
【24h】

Dose reduction of risperidone and olanzapine can improve cognitive function and negative symptoms in stable schizophrenic patients: A single-blinded, 52-week, randomized controlled study

机译:Risperidone和奥氮藻的剂量降低可以改善稳定精神分裂症患者的认知功能和阴性症状:一次盲化,52周,随机对照研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The long-term effects of dose reduction of atypical antipsychotics on cognitive function and symptomatology in stable patients with schizophrenia remain unclear. We sought to determine the change in cognitive function and symptomatology after reducing risperidone or olanzapine dosage in stable schizophrenic patients.
机译:背景:非典型抗精神病药剂量减少对精神分裂症稳定患者认知函数和症状学的长期效应尚不清楚。 在减少稳定精神分裂症患者中,我们试图确定在减少血红腺酮或奥氮藻剂量后的认知功能和症状的变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号